Retention Implementation Guide
1.0.0 - ci-build

Retention Implementation Guide - Local Development build (v1.0.0). See the Directory of published versions

Table of Contents

...0 Table of Contents
...1 Home
....2 Artifacts Summary
....2.1 QuestionnaireCbqHf
....2.2 QuestionnaireKccq
....2.3 QuestionnaireMna
....2.4 QuestionnaireMoca
....2.5 QuestionnairePhq9
....2.6 QuestionnaireSymptoms
....2.7 Caregiver Retention
....2.8 Patient Retention
....2.9 Caregiver Children
....2.10 Caregiver Date of birth
....2.11 Caregiver Employment status
....2.12 Caregiver Highest level of education
....2.13 Caregiver Living situation
....2.14 Caregiver Medical condition
....2.15 Caregiver Sex
....2.16 Patient ABO blood group
....2.17 Patient Country of residence
....2.18 Patient Employment status
....2.19 Patient Ethnicity
....2.20 Patient Height
....2.21 Patient Highest level of education
....2.22 Patient Marital Status
....2.23 Patient Sex
....2.24 ABO blood group Codesystem
....2.25 Angina Codesystem
....2.26 Atrial fibrillation Codesystem
....2.27 Body Temperature Codesystem
....2.28 Body weight Codesystem
....2.29 CPET Codesystem
....2.30 Country of residence Codesystem
....2.31 Dyspnea Codesystem
....2.32 Employment status Codesystem
....2.33 Ethnicity Codesystem
....2.34 Heart rate Codesystem
....2.35 Helper Codesystem
....2.36 Highest level of education Codesystem
....2.37 Intention of LVAD Codesystem
....2.38 Jugular Venous Pressure Codesystem
....2.39 Living situation Codesystem
....2.40 MR Aetiology Codesystem
....2.41 Marital Status Codesystem
....2.42 Medical condition Codesystem
....2.43 Medication Codesystem
....2.44 NYHA class Codesystem
....2.45 No Yes Codesystem
....2.46 Peripheral capillary oxygen saturation Codesystem
....2.47 Peripheral edema Codesystem
....2.48 Questionnaire Symptoms answers Codesystem
....2.49 Retention Codesystem
....2.50 Severe alcohol intake Codesystem
....2.51 Sex Codesystem
....2.52 Smoker Codesystem
....2.53 Systolic blood pressure Codesystem
....2.54 Thyroid disease Codesystem
....2.55 Troponin Codesystem
....2.56 Type death Codesystem
....2.57 Type of CV admission Codesystem
....2.58 Type of LVAD Codesystem
....2.59 Type of rejection Codesystem
....2.60 VAD alarm Codesystem
....2.61 Ventricular stimulation Codesystem
....2.62 6MWT
....2.63 ACEi Captopril
....2.64 ACEi Cilazapril
....2.65 ACEi Enalapril
....2.66 ACEi Fosinopril
....2.67 ACEi Lisinopril
....2.68 ACEi Perindopril
....2.69 ACEi Quinapril
....2.70 ACEi Ramipril
....2.71 ACEi Trandolapril
....2.72 ALAT
....2.73 ALB
....2.74 ALP
....2.75 ARBs Candesartan
....2.76 ARBs Losartan
....2.77 ARBs Olmesartan
....2.78 ARBs Valsartan
....2.79 ASAT
....2.80 Allograft vasculopathy
....2.81 Amiodarone
....2.82 Anemia
....2.83 Angina
....2.84 Antibiotics
....2.85 Anticoagulants Acenocoumarol
....2.86 Anticoagulants Apixaban
....2.87 Anticoagulants Dabigatran
....2.88 Anticoagulants Edoxaban
....2.89 Anticoagulants Rivaroxaban
....2.90 Anticoagulants Warfarin
....2.91 Antiplatelets Aspirin
....2.92 Antiplatelets Clopidogrel
....2.93 Antiplatelets Prasugrel
....2.94 Antiplatelets Ticagrelor
....2.95 Aortic aneurysm
....2.96 Aortic Root diameter
....2.97 AR - Mild
....2.98 AR - Moderate
....2.99 AR - Severe
....2.100 Arrhythmia alarms - Atrial fibrillation
....2.101 Arrhythmia alarms - Bradycardia
....2.102 Arrhythmia alarms - Tachycardia
....2.103 Arterial Hypertension
....2.104 AS - Mild
....2.105 AS - Moderate
....2.106 AS - Severe
....2.107 Ascites
....2.108 Atrial fibrillation
....2.109 B12
....2.110 BORG
....2.111 Basal right ventricle diameter
....2.112 Benign Prostatic hyperplasia
....2.113 Beta-blocker Bisoprolol
....2.114 Beta-blocker Carvedilol
....2.115 Beta-blocker Metoprolol
....2.116 Beta-blocker Nebivolol
....2.117 Body Temperature - Clinical Data
....2.118 Body Temperature - RWD Sensors
....2.119 Body Temperature - Special Event
....2.120 Body weight - Clinical Data
....2.121 Body weight - RWD Sensors
....2.122 Body weight - Special Event
....2.123 Brady-arrhythmias / AV block
....2.124 COPD
....2.125 CPET
....2.126 CPK
....2.127 CRP
....2.128 CRT
....2.129 Calcium
....2.130 Calcium Channel Blockers Amlodipine
....2.131 Calcium Channel Blockers Diltiazem
....2.132 Calcium Channel Blockers Felodipine
....2.133 Calcium Channel Blockers Lacidipine
....2.134 Calcium Channel Blockers Nifedipine
....2.135 Calcium Channel Blockers Verapamil
....2.136 Calories
....2.137 Cancer
....2.138 Capillary oxygen saturation at beginning
....2.139 Capillary oxygen saturation at the end
....2.140 Cardiac index
....2.141 Cardiomyopathy - Congenital
....2.142 Cardiomyopathy - Dilated
....2.143 Cardiomyopathy - Hypertrophic
....2.144 Cardiomyopathy - Ischemic
....2.145 Cardiomyopathy - Other
....2.146 Cardiomyopathy - Restrictive
....2.147 Cardiomyopathy - Toxic
....2.148 CaregiverExample
....2.149 Carotid Artery Disease
....2.150 Cerebrovascular disease
....2.151 Cholesterol
....2.152 Ciclosporin
....2.153 CMV infection after transplant
....2.154 CMV infection requering medical treatment
....2.155 CMV risk profile - High risk
....2.156 CMV risk profile - Low risk
....2.157 CMV risk profile - Moderate risk
....2.158 Conduction delay - Incomplete LBBB
....2.159 Conduction delay - Incomplete RBBB
....2.160 Conduction delay - LAH
....2.161 Conduction delay - LBBB
....2.162 Conduction delay - LPH
....2.163 Conduction delay - non specific
....2.164 Conduction delay - RBBB
....2.165 Coronary artery disease
....2.166 CPK - MB
....2.167 Creatinine
....2.168 CV admission other than HF
....2.169 D-Dimer
....2.170 Date CV admission
....2.171 Date death
....2.172 Date DL infection
....2.173 Date GI bleeding
....2.174 Date heart transplant
....2.175 Date HF admission
....2.176 Date HF decomp
....2.177 Date HF diagnosis
....2.178 Date LVAD implant
....2.179 Date non-CV admission
....2.180 Date stroke
....2.181 Death
....2.182 Deep sleep time
....2.183 Diabetes Mellitus type 1
....2.184 Diabetes Mellitus type 2
....2.185 Diastolic blood pressure - Clinical Data
....2.186 Diastolic blood pressure - RWD Sensors
....2.187 Digoxin
....2.188 Distance
....2.189 Dizziness - Special Event
....2.190 Drive line infection
....2.191 Drive line Reinfection
....2.192 Driveline infections
....2.193 Dyslipidemia
....2.194 Dyspnea - Clinical Data
....2.195 Dyspnea - Special Event
....2.196 EF
....2.197 Echo date
....2.198 Encounter Telephone
....2.199 Encounter Visit
....2.200 Estimated glomerular filtration rate
....2.201 E to CO2 slope
....2.202 Everolimus
....2.203 Ezetimibe
....2.204 Fatigue - Clinical Data
....2.205 Fatigue - Special Event
....2.206 Ferritin
....2.207 Fibrinogen
....2.208 Floors climbed
....2.209 Fluid intake
....2.210 Fractional area change
....2.211 Gastrointestinal bleeding after LVAD
....2.212 Glucose
....2.213 HDL
....2.214 Haematocrit
....2.215 Heart failure related visit
....2.216 Heart rate - Clinical Data
....2.217 Heart rate - ECG
....2.218 Heart rate - RWD Sensors
....2.219 Heart rate - Special Event
....2.220 Heart rate variability
....2.221 Heart transplant
....2.222 Hemoglobin
....2.223 Hepatomegaly
....2.224 HF admission
....2.225 HF decompensation needing iv. Diuretic-inotrops
....2.226 ICD
....2.227 INR
....2.228 Included in heart transplant list due to driveline infections
....2.229 Infection
....2.230 Infection in other LVAD components
....2.231 Inferior Vena Cava (IVC)
....2.232 Insulin
....2.233 Intention of LVAD
....2.234 Interventricular Septum Thickness
....2.235 Iron
....2.236 Ivabradine
....2.237 Jugular venous vressure
....2.238 LDH
....2.239 LDL
....2.240 Left atrium volume
....2.241 Left ventricular Posterior wall thickness
....2.242 Light sleep time
....2.243 Loop diuretics Bumetanide
....2.244 Loop diuretics Furosemide
....2.245 Loop diuretics Torasemide
....2.246 Lvad implant
....2.247 LVED Volume
....2.248 LVES Volume
....2.249 METS
....2.250 Magnesium
....2.251 MR Aetiology
....2.252 MR - Mild
....2.253 MR - Moderate
....2.254 MR - Severe
....2.255 MRA Eplerenone
....2.256 MRA Spironolactone
....2.257 MS - Mild
....2.258 MS - Moderate
....2.259 MS - Severe
....2.260 Mycophenolate mofetil
....2.261 Mycophenolate sodium
....2.262 Nt pro BNP
....2.263 Number HF admission
....2.264 Number HF decompensations
....2.265 Number of CV admissions
....2.266 Number of HF admissions during the previous year
....2.267 Number of non-CV admissions
....2.268 NYHA class
....2.269 O2 max
....2.270 Other antiarrhythmics Flecainide
....2.271 Other antiarrhythmics Mexiletine
....2.272 Other antiarrhythmics Sotalol
....2.273 Other Antidiabetics Alpha-glucosidase inhibitor
....2.274 Other Antidiabetics Dipeptidyl peptidase-4 inhibitors
....2.275 Other Antidiabetics Glucagon-like peptide-1 receptor agonist
....2.276 Other Antidiabetics Metformin
....2.277 Other Antidiabetics Sulfonylurea
....2.278 Other Antidiabetics Thiazolidinedione
....2.279 Other Antihyperlipidemic Drugs Fibrates
....2.280 Other Antihyperlipidemic Drugs Fish oil
....2.281 Other Antihyperlipidemic Drugs PCSK9
....2.282 Other drugs
....2.283 Other non-CV admissions
....2.284 Other - Special Event
....2.285 Patient Example
....2.286 PPI
....2.287 PRCLT
....2.288 Pacemaker
....2.289 Palpitations - Special Event
....2.290 Peripheral artery disease
....2.291 Peripheral capillary oxygen saturation - Clinical Data
....2.292 Peripheral capillary oxygen saturation - RWD Sensors
....2.293 Peripheral capillary oxygen saturation - Special Event
....2.294 Peripheral edema
....2.295 Peripheral hypoperfusion
....2.296 Phosphorus
....2.297 Platelets
....2.298 Pleural effusion
....2.299 Potassium
....2.300 Potassium binders Patiromer
....2.301 Potassium binders Sodium polystyrene sulfonate
....2.302 Potassium binders Sodium zirconium cyclosilicate
....2.303 Potassium sparing diuretics Amiloride
....2.304 Potassium sparing diuretics Triamterene
....2.305 Potassium supplements Aspartate
....2.306 Potassium supplements Bicarbonate
....2.307 Potassium supplements Citrate
....2.308 Potassium supplements Gluconate
....2.309 Potassium supplements Phosphate
....2.310 PQ - PR
....2.311 Previous antibody mediated rejection
....2.312 Previous cardiac surgery
....2.313 Previous coronary revascularization - Percutaneous
....2.314 Previous coronary revascularization - Surgical
....2.315 Previous opportunistic infections
....2.316 Previous rejection episodes - 1R
....2.317 Previous rejection episodes - 2R
....2.318 Previous rejection episodes - 3R
....2.319 Previous rejection episodes - Humoral
....2.320 Previous valvular intervention - Aortic mechanical valve
....2.321 Previous valvular intervention - Mitraclip
....2.322 Previous valvular intervention - Mitral mechanical valve
....2.323 Previous valvular intervention - Other
....2.324 Previous valvular intervention - Surgical aortic valve repair
....2.325 Previous valvular intervention - Surgical mitral valve repair
....2.326 Previous valvular intervention - Surgical tricuspid valve repair
....2.327 Previous valvular intervention - TAVr
....2.328 Previous valvular intervention - Tricuspid device
....2.329 Previous valvular intervention - Tricuspid mechanical valve
....2.330 Pulmonary rales
....2.331 QRS
....2.332 QT
....2.333 Questionnaire Response CBQ-HF
....2.334 Questionnaire Response KCCQ
....2.335 Questionnaire Response MNA
....2.336 Questionnaire Response MoCA
....2.337 Questionnaire Response PHQ-9
....2.338 Questionnaire Response Symptoms
....2.339 RER
....2.340 RVSP
....2.341 Rejection needing treatment in HT
....2.342 Renal insufficiency
....2.343 Resting heart rate
....2.344 Right atrium area
....2.345 Right heart failure - At the time of implantation
....2.346 Right heart failure - One month after implantation
....2.347 S3
....2.348 S4
....2.349 SGLT2i Canagliflozin
....2.350 SGLT2i Dapagliflozin
....2.351 SGLT2i Empagliflozin
....2.352 SGLT2i Ertugliflozin
....2.353 SGLT2i Sotagliflozin
....2.354 Sacubitril - Valsartan
....2.355 Severe alcohol intake
....2.356 Sinus rhythm
....2.357 Sleep interruptions
....2.358 Smoker
....2.359 Sodium
....2.360 Statins Atorvastatin
....2.361 Statins Fluvastatin
....2.362 Statins Lovastatin
....2.363 Statins Pitavastatin
....2.364 Statins Pravastatin
....2.365 Statins Rosuvastatin
....2.366 Statins Simvastatin
....2.367 Steps
....2.368 Steroids Cortisone
....2.369 Steroids Dexamethasone
....2.370 Steroids Hydrocortisone
....2.371 Steroids Methylprednisolone
....2.372 Steroids Prednisolone
....2.373 Steroids Prednisone
....2.374 Stroke after LVAD implantation
....2.375 Sustained ventricular tachicardia one month after implantation
....2.376 Syncope
....2.377 Systolic blood pressure - Clinical Data
....2.378 Systolic blood pressure - RWD Sensors
....2.379 Systolic blood pressure - Special Event
....2.380 TAPSE
....2.381 TSH
....2.382 Tacrolimus Extended release (Envarsus)
....2.383 Tacrolimus Immediate release (Prograft)
....2.384 Tacrolimus Slow release (Advagraft)
....2.385 Tbil
....2.386 Thiazides Bendroflumethiazide
....2.387 Thiazides Chlortalidone
....2.388 Thiazides Hydrochlorothiazide
....2.389 Thiazides Indapamide
....2.390 Thiazides Metolazone
....2.391 Thyroid disease
....2.392 Tot prot
....2.393 TR - Mild
....2.394 TR - Moderate
....2.395 TR - Severe
....2.396 Transient ischemic attack
....2.397 Triglycerides
....2.398 Troponin
....2.399 TS - Mild
....2.400 TS - Moderate
....2.401 TS - Severe
....2.402 Type death
....2.403 Type of LVAD
....2.404 Unplanned emergency department visit date
....2.405 Unplanned emergency department visits
....2.406 Urea
....2.407 Uric acid
....2.408 VAD alarm - Measurement
....2.409 VAD flow - Measurement
....2.410 VAD PI - Measurement
....2.411 VAD PI - Special Event
....2.412 VAD power - Measurement
....2.413 VAD power - Special Event
....2.414 VAD speed - Measurement
....2.415 Vasodilators Hydralazine
....2.416 Vasodilators Isosorbide dinitrate
....2.417 Venous thromboembolism / pulmonary embolism
....2.418 Ventricular stimulation
....2.419 Ventricular tachycardia / Ventricular fibrillation / Resuscitated sudden death
....2.420 Vericiguat
....2.421 White Blood Cells
....2.422 fT3
....2.423 fT4
....2.424 gGT